# Evaluation of Energy Drinks on Electrocardiographic, Vascular and Hematologic Parameters in Healthy Volunteers

> **NCT03021616** · NA · TERMINATED · sponsor: **David Grant U.S. Air Force Medical Center** · enrollment: 2 (actual)

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **OTHER:** energy drink
- **OTHER:** Moxifloxacin 400mg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03021616
- **Lead sponsor:** David Grant U.S. Air Force Medical Center
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-06-26
- **Primary completion:** 2018-03-13
- **Final completion:** 2018-03-13
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Results from sister study at University of the Pacific were conclusive.
- **Last updated:** 2020-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03021616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03021616, "Evaluation of Energy Drinks on Electrocardiographic, Vascular and Hematologic Parameters in Healthy Volunteers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03021616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*